/ Glenmark Pharma Receives Final Approval For Maloff Protect ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Tuesday, 4 July 2017

Medicine and Health product Regulatory Agency (MHRA) granted a final approval for Maloff protect (250mg/100mg atovaquone/proguanil film coated tablets), anti malarial medication, as a pharmacy license in the United Kingdom, to the Glenmark Pharmaceuticals Europe.

It will be used in the prevention of malaria in adults travelling to areas where malaria is prevalent. It has been available only as a prescription medicine in the UK, after this approval patients will be able to purchase Maloff protect without a prescription. 

On Tuesday Glenmark Pharma stocks have gained 0.76% at Rs 644.20/share. The nifty pharma index gained 20 points or 0.67% on3066.60 levels on Intraday trade and BSE healthcare index gained over 39 points or 0.28% at 14266.33 levels.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.co
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔
Give a Missed Call for Free Trial - 09699997717 ✔